hydralazine has been researched along with mk 761 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldwin, JJ; Engelhardt, EL; Hirschmann, R; Lumma, WC; Lundell, GF; Ponticello, GS; Raab, AW; Scriabine, A; Sweet, CS | 1 |
Atkinson, JG; Baldwin, JJ; Engelhardt, EL; Hirschmann, R; Ponticello, GS; Scriabine, A; Sweet, CS; Wasson, BK | 1 |
Baldwin, JJ; Ludden, CT; Morgan, G; Scriabine, A | 1 |
3 other study(ies) available for hydralazine and mk 761
Article | Year |
---|---|
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Chemistry, Pharmaceutical; Dogs; Hypertension; Imidazoles; Rabbits; Rats; Structure-Activity Relationship; Vasodilator Agents | 1979 |
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Female; Heart Rate; Hypertension; Isoproterenol; Male; Pyridines; Rats; Regional Blood Flow; Structure-Activity Relationship; Vasodilator Agents | 1980 |
Antihypertensive and cardiac effects of two novel beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Butylamines; Heart; Heart Rate; Hydralazine; Hypertension; Imidazoles; Myocardial Contraction; Pyridines; Rats | 1979 |